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Background: Mesenchymal Stem Cells (MSC) are important candidates for therapeutic applications due to their
ex vivo proliferation and differentiation capacity. MSC differentiation is controlled by both intrinsic and extrinsic
factors and actin cytoskeleton plays a major role in the event. In the current study, we tried to understand the
initial molecular mechanisms and pathways that regulate the differentiation of MSC into osteocytes or adipocytes.
Results: We observed that actin modification was important during differentiation and differentially regulated
during adipogenesis and osteogenesis. Initial disruption of actin polymerization reduced further differentiation of
MSC into osteocytes and osteogenic differentiation was accompanied by increase in ERK1/2 and p38 MAPK
phosphorylation. However, only p38 MAPK phosphorylation was down regulated upon inhibition of actin
polymerization which as accompanied by decreased CD49E expression.
Conclusion: Taken together, our results show that actin modification is a pre-requisite for MSC differentiation into
osteocytes and adipocytes and osteogenic differentiation is regulated through p38 MAPK phosphorylation. Thus by
modifying their cytoskeleton the differentiation potential of MSC could be controlled which might have important
implications for tissue repair and regeneration.
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The multipotential differentiation capacity of mesenchy-
mal stem cells (MSC) makes them important candidates
for tissue repair and regeneration of bone [1-3]. Under
physiological conditions in the bone marrow, the balance
between adipogenesis and osteogenesis of MSC has to be
maintained to prevent diseases such as osteoporosis that
occurs due to decreased osteogenic differentiation of MSC
[1,4,5]. Since adipocytes and osteocytes are a part of the
niche cells in the bone marrow, the balance between oste-
ocytes, adipocytes were found to regulate hematopoiesis
and tissue homeostasis [6,7]. Thus, a better understanding
of the cell intrinsic changes that occur during MSC differ-
entiation is required for cell therapy and tissue repair.
Morphology and cytoskeleton of MSC undergo exten-
sive modifications during differentiation in addition to* Correspondence: bithiahgj@iitg.ernet.in
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reproduction in any medium, provided the orthe gene expression changes [8-11]. Cytoskeletal modifi-
cation brought about by Rho GTPase has been found to
be a major contributor of Mesenchymal Stem Cell (MSC)
differentiation and migration [12-14]. During the early
stages of differentiation, cues from the microenvironment
might affect the differentiation potential and also alter the
lineage commitment [15]. The matrix stiffness on which
MSC grow has also been reported to direct MSC cell
lineage [16]. In addition, substrates with different affinity
for the cell surface receptors have been reported to in-
fluence MSC differentiation fate. High affinity for the
extracellular matrix (ECM) substances by allowing cells
to adhere, flatten and spread favored osteogenic differ-
entiation, whereas low affinity for the substrate favored
adipogenic differentiation. Cell shape regulated by ECM
properties and initial seeding densities has been re-
ported to be important regulators of lineage commit-
ment [17]. Integrins form the actin-linked cell-matrix
junctions through which the ECM substances such as fi-
bronectin are linked to actin cytoskeleton [13]. Integrinl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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termines the fate of the cells during differentiation [17,18].
Integrin α5 that was upregulated during osteogenic differ-
entiation has been found to be an important regulator of
osteogenic differentiation. Silencing of integrin α5 abo-
lished osteogenic differentiation [18].
In this study, we investigated the role of actin cytoskel-
eton in controlling MSC differentiation and whether lineage
specification could be controlled by modifying actin cyto-
skeleton. We report here for the first time that actin cyto-
skeleton modification is a very early event during MSC
differentiation into adipocytes and osteocytes and might
apply to other lineages as well. We found that inhibition
of actin polymerization through CYD treatment inhibited





sone, ascorbic acid, indomethacin, insulin, paraformalde-
hyde, human fibronectin, Cytochalasin D (CYD), Phalloidin-
tetramethylrhodamine B isothiocyanate (TRITC) and cell
culture tested bovine serum albumin (BSA) were purchased
from Sigma-Aldrich (Germany). Fluorescence-conjugated
monoclonal antibodies for CD13, CD45, CD49d, CD49e,
CD73, CD90, CD105, HLA-I, p38MAPK, ERK and NFkB
were from BD Biosciences (USA). Reverse transcription re-
agents were from Applied Biosystems (USA).
Isolation of MSC from bone marrow
MSC were isolated from patients referred to hematology
department of Gauhati Medical College Hospital after
ethical consent following local ethical guidelines. The
average age of the bone marrow donors was ~28 years.
Bone marrow was aspirated from iliac crest and the cells
were collected in heparin tubes and after red cell lysis,
plated in a tissue culture plate pre-coated with fibronectin
(10 ng/cm2) in DMEM low glucose medium supplemented
with 10% FCS, penicillin and streptomycin. Adherent col-
onies of spindle shaped cells obtained after 2–3 weeks
were sub-cultured and used for further experiments.
Differentiation and phenotyping
MSC isolated from the BM samples were differentiated
into adipogenic and osteogenic lineages as previously
described [12]. Media was changed every 2–3 days and
adipogenic differentiation was assessed by Oil-red O stain-
ing and osteogenic differentiation by alkaline phosphatase
staining. The cells were enumerated microscopically to
determine the number of differentiated cells.
Bone marrow MSC were phenotyped for the expression
of mesenchymal cell surface markers by flow cytometry.
The cells were trypsinized and stained with fluorescentlyconjugated monoclonal antibodies against CD13, CD29,
CD45, CD49a, CD49b, CD49e, CD73, CD90, CD104,
CD105 and HLA-I. The cells were incubated on ice for
30 minutes, washed and analysed by FACS calibur (BD
Pharmingen). Propidium iodide was used for live/dead
discrimination.
Phospho staining for flow cytometry
Cells were trypsinized and fixed immediately with 4%
formaldehyde and permeabilised with 100% methanol. The
cells were stained with fluorescent conjugated antibodies
that specifically bind to the phosphorylated form of pro-
teins for 1 hour at room temperature and analysed by flow
cytometry.
Actin staining
Cells grown on fibronectin coated cover slips or plates were
fixed with paraformaldehyde (4%), permeabilised with Tri-
ton X-100 (0.1%) and stained with TRITC conjugated phal-
loidin overnight at 4°C. After washing with PBS, the cells
were mounted and documented using Nikon CCD camera.
Real-time quantitative PCR
Quantitative real-time PCR was performed to quantify
the transcript level of different genes. RNA was isolated
using Trizol reagent and reverse transcribed into cDNA
using MultiScribe reverse transcriptase (Applied Biosys-
tems, USA) and real-time PCR was performed using
SYBR Green reagents (Applied Biosystems, USA). The
primers used were: GAPDH forward 5′-GGGAAGGTG
AAGGTCGGAGT-3′, GAPDH reverse 5′-GGGTCATT
GATGGCAACAATA-3′, ACTIN forward 5′- GCACAG
AGCCTCGCCTTT-3′, ACTIN reverse 5′- CGCCCACA
TAGGAATCCTTC-3′, ADIPONECTIN forward 5′-CCAT
CTCCTCCTCACTTCCA-3′, ADIPONECTIN reverse 5′-
GTGCCATCTCTGCCATCAC-3′, PPARg forward 5′-GA





Inhibition of actin polymerization was performed by addi-
tion of CYD (Sigma) for different time points at various
concentrations. For recovery after CYD treatment, the cells
were washed twice with PBS, normal growth media or in-
duction media was added for the indicated time periods.
Scanning Electron Microscopy (SEM)
Cells were cultured on fibronectin coated coverslips, fixed
with 2.5% gluteraldehyde and dehydrated with graded series
of ethanol (30%, 50%, 70%, 90% and 100%). The cells were
then gold coated with a sputter coater and viewed under
Scanning Electron Microscope (Leo 1430vp, Germany).
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Statistical analysis was performed using SPSS software and
values of p < 0.05 were considered statistically significant.
Results
To understand the molecular events preceding and driv-
ing the differentiation of MSC into various lineages, we
studied the role of actin cytoskeleton during differenti-
ation of MSC into osteocytes and adipocytes. For this,
human MSC were cultured in adipogenic or osteogenic
induction medium and their change in morphology and
cytoskeleton was monitored during early and late stages
of differentiation. SEM images of differentiated cells clearly
revealed that differentiated cells have an altered morph-
ology. After 14 days of culture in differentiation media, the
cells attained a globular shape during adipogenesis and the
cells became angular with increased cell extensions during
osteogenesis whereas the undifferentiated cells were spin-
dle shaped (Figure 1A). We found that during adipogenic
differentiation, the cells increased in their size gradually
until day 14 whereas during osteogenic differentiation, the
cell size remained relatively unaltered (Figure 1B).
To determine the initial cellular changes that occur
during MSC differentiation, we analysed the status of actin
cytoskeleton by staining the cells with TRITC conjugated
phallodin at various stages of differentiation. Undifferenti-
ated MSC in vitro showed parallel actin filamentsFigure 1 Morphology and cell size during MSC differentiation. (A) Sca
osteocytes or adipocytes. The cells were left uninduced (i) or induced into
media for 14 days. Osteocytes attained an angular shape whereas the adip
image is shown. (B) Flow cytometric analysis of cell size by forward scatter
adipocytes. The cells were analysed after day 0, 1, 3, 7, 14 days of inductiontraversing the entire length of the spindle shaped cells as
seen in Figure 2A. In undifferentiated MSC, the actin
cytoskeleton arrangement remained unaltered during vari-
ous passages, however, within 24 hours of induction into
adipocytes or osteocytes, the cells underwent significant
actin cytoskeleton modification (Figure 2A) which was
accompanied by increase in formation of oil droplets in
the adipo-induced cells or alkaline phosphatase activity in
osteo induced cells. Actin cytoskeleton remodeling contin-
ued until 14–21 days where osteogenic induction resulted
in the formation of peri-nuclear actin bundles framing
the angular cell body showing abundant stress fibres
and increased actin polymerization (Figure 2A). During
adipogenic differentiation, the cells showed discontinuous
actin filaments forming a network like structure. When
the cells started accumulating oil-droplets, actin fila-
ments formed a disrupted network around the oil-droplets
(Figure 2A). The changes in actin modification were very
early during differentiation where the filamentous actin
(F-actin) concentration increased within 24 hours during
osteogenesis but decreases during adipogenesis (Figure 2B).
Thus the change in morphology, cell shape, size and actin
remodeling were important cellular events that defined
MSC differentiation into adipocytes or osteocytes.
Given the significant differential changes in the actin
cytoskeleton during osteogenic or adipogenic differenti-
ation of MSC as early as 24–48 hours of induction, wenning electron microscope images of MSC differentiated into
either osteocytes (ii) or adipocytes (iii) in their respective induction
ocytes become globular in shape with oil droplet. Representative
measurement in MSC differentiated into either osteocytes or
into osteocytes or adipocytes. Representative histograms are shown.
Figure 2 Actin cytoskeleton rearrangement during MSC differentiation. (A) MSC were grown in media containing osteogenic or adipogenic
inducers for 24 hours, 3 days, 7 days and 14 days or left uninduced (0 hr) and F-actin was visualised by staining with phalloidin-TRITC.
Photomicrographs are representative images from 3 independent experiments. (B) Flow cytometric analysis of uninduced (CONTROL) or MSC
induced with osteogenic or adipogenic media for 24 hour and stained with phalloidin-TRITC. X-axis represents the F-actin fluorescence intensity,
representative graphs are shown. Unstained cells were used to obtain the auto fluorescence levels during flow cytometry.
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requisite for MSC differentiation and if differentiation
could be controlled by actin cytoskeleton modification.
Although the actin remodelling initiated within 24 hours
of induction of differentiation (Figure 2A), the changes
in gene expression was very minimal. To understand the
role of actin remodelling in driving or inhibiting the dif-
ferentiation of MSC into either osteocytes or adipocytes,
the cells were treated for different time periods with
CYD, in the presence or absence of induction media.
Inhibition of actin polymerisation was evident within 24
hours of treatment of MSC with CYD and effective con-
centration was found to be 100–1000 ng/ml without
compromising the cell viability (Figure 3A). Flow
cytometric analysis showed decreased fluorescence in
cells treated with CYD compared to control cells when
stained for F-actin (Figure 3B). This effect of CYD on
actin polymerisation could be reversed when the inhibi-
tor was removed and cells were allowed to recover in
the respective induction media or normal media (Data
not shown).
Interestingly, when MSC were treated with CYD for 7
days in the presence of osteogenic induction media, there
was a significant reduction in osteocytes as evidenced bydecrease in alkaline phosphatase positive cells (Figure 3D-
F). When CYD treatment period was extended up to 14
days in osteogenic induction media, there was a 10-fold re-
duction in the osteogenic differentiation showing little or
no actin filaments in the treated samples (Figure 3C-E).
Consistent with the decreased alkaline phosphatase activity,
there was a significant decrease in OSTEOCALCIN levels
when the cells were treated with CYD for different dura-
tions (Figure 3F).
We found that 24 hours of CYD treatment was sufficient
to reduce osteoblast differentiation by 50% even though
the cells were allowed to recover for 48 hours without
CYD in the osteogenic induction media (Figure 4A). How-
ever, this recovery period of 48 hours in the induction
media was sufficient to allow the remodelling of actin
where polymerised actin (F-actin) was seen in the differen-
tiating cells. Furthermore, when the cells were treated with
CYD for 3 days and allowed to recover for 4 days in the in-
duction media, there was 3-fold decrease in the osteogenic
differentiation potential where actin cytoskeleton rear-
rangement appeared normal (Figure 4B, C).
In contrast, when the cells were treated with CYD dur-
ing adipogenic differentiation there was a significant in-
crease in the oil-Red O positive adipocytes. Three days
Figure 3 Effect of CYD treatment on osteogenic differentiation. (A) MSC were left untreated (CONTROL) or treated with CYD (100 ng/ml) for
24 hours in the normal growth media and stained with phalloidin-TRITC showing less F-actin in CYD treated cells. (B) Flow cytometric analysis of
MSC untreated (grey line) and treated with CYD (100 ng/ml, black line) for 24 hours stained with phalloidin-TRITC and x-axis shows the TRITC
fluorescence. Grey filled is unstained control. (C) MSC were induced to undergo osteogenesis without (CONTROL) or with CYD (+CYD) for 7 or 14
days and F-actin visualised by staining with phalloidin-TRITC. (D) MSC were induced to undergo osteogenesis without (CONTROL) or with CYD
(+CYD) for the indicated time period showing the fold increase in ALP positive cells. Blue colour represents alkaline phosphatase stained cells.
ALP positive cells (E) or Osteocalcin expression (F) in MSC induced to undergo osteogenic differentiation without (CONTROL) or with CYD (CYD)
for indicated time periods. X-axis (E,F) represents the number of days in differentiation media and y-axis indicates the fold increase in ALP
positive cells compared to day 1 (CONTROL, E) or normalised OSTEOCALCIN expression (F). Representative photomicrographs or flow cytometric
histogram is shown. ALP stands for alkaline phosphatase. Values are mean ± SD, n = 3-4. ** P < 0.005, *** p < 0.0005.
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duction was sufficient to increase adipogenic differenti-
ation by ~30% (Figure 5A). During the recovery period,
the actin cytoskeleton reverted back to its cross linked
form as seen in normal adipocytes. To understand fur-
ther the effect of CYD treatment on adipogenic differen-
tiation, MSC were treated with cytochalsin D for 7 days,
that is, throughout the adipogenic induction period.Surprisingly we found that there was a 3-fold increase in
the adipogenic differentiation (oil-Red O positive cells)
compared to untreated controls. To further confirm the
possibility that inhibition of cytoskeleton increases the
adipogenic differentiation capacity of MSC, the treatment
with CYD was extended to 14 days in the induction
media. Consistent with the 7 days result, there was a 2.8
fold increase in the adipogenic differentiation of MSC
Figure 4 Effect of CYD treatment on osteogenic differentiation. Percentage of ALP positive cells (A,B) or OSTEOCALCIN (C) expression in MSC
induced to undergo osteogeneis without (CONTROL) or with CYD (+CYD) treatment. CYD treatment was given for initial one day (1D) during 3
days of osteogenic induction (A) or for initial 3 days (3D) during 7 days osteogenesis induction (B,C). F-actin staining with phalloidin-TRITC of
CYD treated MSC in each condition is shown in the inset. Values are mean ± SD, n = 3-4. ** P < 0.005, *** p < 0.0005, ALP stands for
alkaline phosphatase.
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duction compared with the cells cultured with the normal
induction media (Figure 5B, C). Notably, the cells treated
with CYD for 7 days or 14 days without the recovery
period lacked actin polymerisation when stained with
phalloidin TRITC (Figure 5B). To confirm an increase in
adipogenic differentiation during CYD treatment, we
quantified the mRNA levels of adiponectin (ADIPOQ) and
peroxisome proliferator-activated receptor gamma (PPARG)
in adipo-induced cells. Consistent with the increased oil-
red O positive cells, there was a subsequent increase in the
expression levels of ADIPOQ and PPARG in CYD treated
cells (Figure 5D).
In order to determine whether inhibition of actin poly-
merization prior to induction of differentiation could
affect the differentiation potential of MSC, we pre-treated
MSC with CYD for 3 days and allowed the cells to differ-
entiate into osteocytes and adipocytes in the absence of
CYD. There was an increase in adipogenic differentiation
potential and a significant decrease in the osteogenic
differentiation potential was observed (Additional file 1:
Figure S1 A-C). In addition, CYD pre-treatment in the ab-
sence of induction factors was sufficient to decrease
OSTEOCALCIN expression but induce PPARG expression
in MSC (Additional file 1: Figure S1 D, E). This confirms
the earlier observation that cytoskeletal modification was
an early event during MSC differentiation.
To understand the molecular pathways affected by actin
modification we studied the activation levels of NFκB, p38
and ERK1/2 MAPKs during MSC differentiation into
adipocytes or osteocytes. We found that phosphorylated
levels of p38 and ERK1/2 MAPKs increased during osteo-
genesis (Figure 6A-C) but no significant difference was seen
in NFκB phosphorylation. On treatment with CYD, there
was a significant decrease in the phosphorylated levels ofp38MAPK not ERK1/2 MAPK during both osteogenesis
and adipogenesis. Hence, we can conclude that even
though phopshorylated levels of both p38 and ERK1/2
MAPK increased during osteogenesis, it is through
p38MAPK pathway in MSC, CYD downregulates osteo-
genic differentiation (Figure 6A-C).
Actin is linked to the external micro environment
through integrins and reports suggest that integrins me-
diate cytoskeleton organization, gene expression and dif-
ferentiation [19,20] and so we sought to find out the
changes in integrin expression during osteogenesis and
adipogenesis. There was a four-fold increase in the fibro-
nectin receptor CD49E when the cells differentiated into
osteoblasts whereas no significant difference was observed
in adipo differentiated cells. We found a 50% reduction
in CD49E expression in osteoblasts when the cells were
treated with CYD during differentiation (Figure 6D).
Taken together, our results strongly suggest that cyto-
skeletal changes are very important for MSC differenti-
ation into adipocytes and osteocytes and it is a very early
cellular event which preceeds the gene expression
changes. Actin modification seems to regulate osteo-
genic differentiation through p38 MAPK pathway.
Discussion
In the current study, we report that changes in cell shape
and actin cytoskeleton remodeling were important events
during MSC differentiation into adipocytes and osteocytes.
Cytoskeleton modification was an early event during
differentiation and it occurred as early as 24 hours after
the addition of respective induction media. The cytoskel-
eton was differentially modified during osteogenic and
adipogenic differentiation where there was more actin
polymerization and the cells acquired more stress fibres
and actin bundles were clearly visible during osteogenic
Figure 5 Effect of CYD treatment on adipogenic differentiation. (A) Percentage of MSC differentiated into adipocytes for 7 days without
(CONTROL) or with CYD treatment (+CYD) was determined by ORO staining where CYD treatment was done for the initial 3 days (3D) during the
7 days induction period. F-actin staining with phalloidin-TRITC for CYD treated MSC is shown in the inset. (B) F-actin and ORO staining in MSC
induced to differentiate into adipocytes without (CONTROL) or with CYD treatment (+CYD) for 7 or 14 days. Representative photomicrographs are
shown. (C) Fold increase in ORO positive cells in MSC were induced to undergo adipogenesis without (CONTROL) or with CYD (+CYD) for the
indicated time periods: (D) ADIPOQ and PPARG mRNA levels in untreated (CONTROL) or CYD treated (+CYD) MSC induced to undergo
adipogenesis for the indicated time periods. Values are mean ± SD, n = 3-4. * p < 0.05, ** P < 0.005, *** p < 0.0005, ORO stands for Oil red O.
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reduction in actin polymerization where actin filaments
occurred as a broken network like structure. Although the
cell size increased during adipogenic differentiation, more
F-actin was formed during osteogenic differentiation. These
differences suggest that these changes might be due to the
different mechanical strength required for osteocytes and
adipocytes [21]. Increased polymerization and stress fibres
might render osteocytes which form the bones in the body
with more mechanical strength required to withstand the
physical stress [9]. Although RHO GTPases have been
found to be involved in regulating the differentiation
of MSC [14], our results suggest that cytoskeletonmodification seems to be the early event directing the dif-
ferentiation of these cells.
Engler et al. reported that matrix elasticity determines
the lineage commitment in MSC [16], but our experi-
ments clearly show that under uniform matrix elasticity,
the cytoskeletal organization directs the lineage commit-
ment. Although changes in the cytoskeleton during os-
teogenesis has been reported [8,9], we show here that
cytoskeletal modification is not an effect of differentiation
but a contributing factor for differentiation. Gene expres-
sion studies also confirm the observation that cytoskeleton
modification through CYD treatment was sufficient to
modify MSC differentiation by increasing PPARG levels
Figure 6 p38MAPK and CD49E expression changes during MSC differentiation. MSC were differentiated into osteocytes (OS) or adipocytes
(AD) in the absence (UNTR) or presence of CYD (+CYD) for 3 days and the phosphorylated levels of p38 MAPK (A) and ERK1/2 MAPK (C) was
determined by flow cytometry. Y-axis in figure A and C shows the relative phosphorylated levels of p38 MAPK or ERK1/2 MAPK compared to
undifferentiated untreated control cells (CONTROL). B. Representative flow cytometric histrograms of MSC differentiated into osteocytes (OS) or
adipocytes (AD) which were left untreated (UNTR) or treated with CYD (+CYD) stained for phosphorylated form of p38MAPK. Red line is the
isotype control and blue line is the sample. D. Flow cytometric analysis of CD49E surface expression in MSC differentiated into osteocytes (OS) or
adipocytes (AD) which were left untreated (UNTR) or treated with CYD (+CYD) for 14 days. Values are mean ± SD, n = 3, *p < 0.05, **p < 0.005,
*** p < 0.0005.
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could differentiate into osteocytes after the removal of
CYD, we observed a significant decrease in the differenti-
ation potential which could be attributed to the decrease
in OSTEOCALCIN levels during CYD treatment. Previous
studies have shown that beta-actin attaches itself to the
surface of fat droplets indicating a possible role for beta-
actin in lipid metabolism [22]. In addition, steroid re-
sponding cells which include adipocytes seem to maintain
a higher level of monomeric actin which facilitates choles-
terol transport [23,24]. This might be the reason for in-
creased adipogenesis and increase in PPARG levels seen in
our study when actin polymerization into F-actin was
inhibited by CYD treatment resulting in higher amounts
of G-actin in the form of beta-actin in the cells.We also found that osteogenic differentiation caused an
up regulation of CD49E as reported by others [18] and
CYD treatment resulted in reduced osteogenic potential of
cells which in turn might have caused the decrease in
CD49E expression. From this experiment we conclude that
cytoskeletal changes precede gene expression and integrity
of actin cytoskeleton was required for osteogenic differ-
entiation as reported also in other cell types [20]. An
interesting finding in our study is that decreased actin
polymerization facilitated adipogenesis in contrast to its
inhibiting effects on osteogenesis.
Yang et al. suggested that actin binding could regulate
p38 MAPK activity [25] and several studies reported the
importance of p38 MAPK in regulating osteogenic differ-
entiation. P38 MAPK activity positively regulated BMP-2,
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it was found not to be important for mechanical strain
induced osteogenesis [29]. Although we did not find any
significant decrease in osteogenesis on addition of p38
MAPK inhibitor SB208530 (data not shown), there was
an increased phosphorylation of p38 MAPK which was
effectively down regulated by actin polymerization inhib-
ition. However, the role of actin in regulating p38 MAPK
during osteogenesis requires further study.
Conclusion
Taken together, our results suggest that differential actin
remodeling occurs during MSC differentiation which
precedes the gene expression changes. This actin modifi-
cation regulates p38 MAPK phosphorylation which can
be modified by CYD treatment. The combined effect of
actin polymerization and p38 phosphorylation regulates
osteogenic differentiation.
Additional file
Additional file 1: Figure S1. MSC were pre-treated with CYD (+CYD
(3D)) for 3 days and allowed to differentiate into osteocytes (A, B) or
adipocytes (C) for 14 days in the respective induction media without
CYD. Osteogenic and adipogenic differentiation was determined by
staining for alkaline phosphatase (ALP) and oil-red O (ORO) respectively.
Values are mean ± SD, n = 3. Representative microphotographs are
shown, the bar represents 200μm. Real-time PCR analysis of OSTEOCALCIN (D)
and PPARG (E) expression levels in MSC treated without (UNTR) or with CYD
(+CYD (7D)) for 7 days. Values are mean ± SD, n = 3. * p < 0.05, ** P < 0.005.
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